Advertisement
Demo

Lilly to buy cancer drug developer AurKa Pharma

May 15, 2018 , CNBC Health
Eli Lilly will buy AurKa Pharma in a deal potentially worth up to $575 million.

Read the full story...


Trending healthcare news keywords at this moment

congo ebola outbreak cancer drug treatment study risk patients bill care medical trump heart fda approves opioid tied disease blood prices tip healthcare women lower